COVAXIN
- Hyderabad
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Hyderabad: The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for the age group of 6-12 years. The Hyderabad-based Pharma company Bharat…
- Top Stories
SII, Bharat Biotech cut prices of COVID-19 vaccines for pvt hospitals to Rs 225
New Delhi: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs…
- India
Covid precaution dose for 18+ age group at private vaccination centres from Apr 10
New Delhi: Precaution dose of COVID-19 vaccines will be available to all aged above 18 years at private vaccination centres from April 10, the Union Health Ministry announced on Friday. According to…
- Hyderabad
Bharat Biotech temporarily slows down COVAXIN production
Hyderabad: Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.…
- Hyderabad
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotech
Hyderabad: Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States. “Ocugen, Inc (NASDAQ: OCGN) announced that the…
- India
Regular market approval granted for Covishield, Covaxin for use in adult population
New Delhi: India’s drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said. The approval…
- Hyderabad
Ensure only Covaxin is given to 15-18 group: Bharat Biotech
Hyderabad: Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group. The Hyderabad-based vaccine maker on Tuesday said that it “received…
- India
One year on, vaccines still most acceptable weapon against COVID-19
New Delhi: With India’s inoculation drive against COVID-19 completing one year, vaccines remain the most effective weapon against the deadly virus though a number of drugs and other methods, including chanting of…
- India
Over 14.84 cr unutilized COVID-19 vaccine doses still available with States, UTs: Centre
New Delhi: The Centre on Saturday said that more than 14.84 crore balance and unutilized COVID-19 vaccine doses are still available with the States and UTs to be administered. An official statement…
- India
DCGI to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today
New Delhi: Drugs Controller General of India (DCGI)’s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively…
- India
Covaxin booster can neutralise Omicron: Bharat Biotech
New Delhi: Covaxin’s booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted at US’ Emory University, Bharat Biotech announced on Wednesday. Earlier studies…
- India
Over 2 crore children in 15-18 age group vaccinated with first dose so far: Mandaviya
New Delhi: Over 2 crore teenagers in the age group of 15-18 years have received their first dose of COVID-19 vaccine in less than a week of the inoculation drive being launched…
- Hyderabad
Administer only Covaxin to 15-18 age group: Bharat Biotech to healthcare workers
Hyderabad: Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the…
- Andhra Pradesh
Andhra tops list with 39.8% of 15-17 yrs administered first dose of COVID-19 vaccine: Govt
New Delhi: Andhra Pradesh tops the list with 39.8 per cent of the target population in the age group of 15-17 years being administered the first dose of COVID-19 vaccine in the…
- Hyderabad
Mix & Match of Covid vaccines evokes 4 times antibody response, says Hyderabad study
Hyderabad: Mixing of COVID-19 vaccines Covaxin and Covishield as first and second doses or vice versa was found to be four times effective, a study by city-based AIG Hospitals along with a…
